Cambridge Health Alliance, Somerville, Massachusetts.
University of Mississippi, University.
JAMA. 2022 Jul 26;328(4):393-395. doi: 10.1001/jama.2022.9734.
This study examines the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters.
本研究考察了在 FDA 发出警告信后,产品召回的频率以及补充剂中是否存在 FDA 禁止的药物。